| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +718.1% |
| Cost of Revenue | $395K | +779.7% |
| R&D Expense | $90K | -75.2% |
| SG&A Expense | $548K | +0.7% |
| Operating Income | -$1.2M | +31.7% |
| Interest Expense | $264K | +15.1% |
| Pre-tax Income | -$1.3M | +32.7% |
| Income Tax | $0 | — |
| Net Income | -$1.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106K | -44.8% |
| Current Assets | $307K | +36.1% |
| Total Assets | $869K | -44.0% |
| Current Liabilities | $4.1M | +9.6% |
| Total Liabilities | $4.1M | +9.7% |
| Stockholders' Equity | -$3.2M | -48.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$202K | +83.6% |
| Investing Cash Flow | -$72K | — |
| Financing Cash Flow | $188K | -86.2% |
| +32.7% |
| EPS (Basic) | -$0.34 | -3300.0% |
| EPS (Diluted) | -$0.34 | -3300.0% |